Published in Biochemistry on August 31, 2007
What are the sources of hydrogen peroxide production by heart mitochondria? Biochim Biophys Acta (2010) 1.02
NADH/NAD+ interaction with NADH: ubiquinone oxidoreductase (complex I). Biochim Biophys Acta (2008) 0.99
Molecular identification of the enzyme responsible for the mitochondrial NADH-supported ammonium-dependent hydrogen peroxide production. FEBS Lett (2010) 0.89
Evaluation of anti-bacterial and wound healing activity of the fruits of Amorpha fruticosa L. Afr J Tradit Complement Altern Med (2013) 0.88
Reversible dissociation of flavin mononucleotide from the mammalian membrane-bound NADH: ubiquinone oxidoreductase (complex I). FEBS Lett (2007) 0.78
Investigation of NADH binding, hydride transfer, and NAD(+) dissociation during NADH oxidation by mitochondrial complex I using modified nicotinamide nucleotides. Biochemistry (2013) 0.77
Allosteric nucleotide-binding site in the mitochondrial NADH:ubiquinone oxidoreductase (respiratory complex I). FEBS Lett (2011) 0.76
Imeglimin prevents human endothelial cell death by inhibiting mitochondrial permeability transition without inhibiting mitochondrial respiration. Cell Death Discov (2016) 0.75
Assembly of a chimeric respiratory chain from bovine heart submitochondrial particles and cytochrome bd terminal oxidase of Escherichia coli. FEBS Lett (2009) 0.75
Structure of the hydrophilic domain of respiratory complex I from Thermus thermophilus. Science (2006) 4.47
Energy converting NADH:quinone oxidoreductase (complex I). Annu Rev Biochem (2006) 3.88
The NADH:ubiquinone oxidoreductase (complex I) of respiratory chains. Q Rev Biophys (1992) 3.06
Bovine complex I is a complex of 45 different subunits. J Biol Chem (2006) 3.01
The mechanism of superoxide production by NADH:ubiquinone oxidoreductase (complex I) from bovine heart mitochondria. Proc Natl Acad Sci U S A (2006) 2.78
Respiratory complex I: mechanistic and structural insights provided by the crystal structure of the hydrophilic domain. Biochemistry (2007) 2.03
The proton-translocating NADH-quinone oxidoreductase in the respiratory chain: the secret unlocked. Biochemistry (2003) 1.98
The respiratory-chain NADH dehydrogenase (complex I) of mitochondria. Eur J Biochem (1991) 1.96
Tight-binding inhibitors-I. Kinetic behavior. Biochem Pharmacol (1975) 1.89
Catalytic properties of the mitochondrial NADH-ubiquinone oxidoreductase (complex I) and the pseudo-reversible active/inactive enzyme transition. Biochim Biophys Acta (1998) 1.77
Studies on the respiratory chain-linked dihydrodiphosphopyridine nucleotide dehydrogenase. I. Assay of the enzyme in particulate and in soluble preparations. J Biol Chem (1962) 1.73
Generation of superoxide by the mitochondrial Complex I. Biochim Biophys Acta (2006) 1.67
Studies on the respiratory chain-linked reduced nicotinamide adenine dinucleotide dehydrogenase. 13. Binding sites of rotenone, piericidin A, and amytal in the respiratory chain. J Biol Chem (1968) 1.59
Two protons are pumped from the mitochondrial matrix per electron transferred between NADH and ubiquinone. FEBS Lett (1984) 1.46
The proton-pumping respiratory complex I of bacteria and mitochondria and its homologue in chloroplasts. FEBS Lett (1995) 1.46
Complex I: a chimaera of a redox and conformation-driven proton pump? J Bioenerg Biomembr (2001) 1.38
Organization of iron-sulfur clusters in respiratory complex I. Science (2005) 1.33
-->H+/2e- stoichiometry in NADH-quinone reductase reactions catalyzed by bovine heart submitochondrial particles. FEBS Lett (1999) 1.32
Studies on the electron transfer pathway, topography of iron-sulfur centers, and site of coupling in NADH-Q oxidoreductase. J Biol Chem (1988) 1.28
Slow active/inactive transition of the mitochondrial NADH-ubiquinone reductase. Biochim Biophys Acta (1990) 1.26
Conformation-driven and semiquinone-gated proton-pump mechanism in the NADH-ubiquinone oxidoreductase (complex I). FEBS Lett (2005) 1.25
Energy transduction by respiratory complex I--an evaluation of current knowledge. Biochem Soc Trans (2005) 1.24
Substrate-induced conformational change in bacterial complex I. J Biol Chem (2004) 1.20
NADH-ubiquinone oxidoreductase. Biochim Biophys Acta (1976) 1.20
Proton-translocation by membrane-bound NADH:ubiquinone-oxidoreductase (complex I) through redox-gated ligand conduction. Biochim Biophys Acta (1997) 1.16
Steady-state kinetics of high molecular weight (type-I) NADH dehydrogenase. Biochim Biophys Acta (1976) 1.10
The complex I from Rhodobacter capsulatus. Biochim Biophys Acta (1998) 1.08
Catalytic sector of complex I (NADH:ubiquinone oxidoreductase): subunit stoichiometry and substrate-induced conformation changes. Biochemistry (1994) 1.07
Proton pumping by NADH:ubiquinone oxidoreductase. A redox driven conformational change mechanism? FEBS Lett (2003) 1.05
From NADH to ubiquinone in Neurospora mitochondria. Biochim Biophys Acta (2002) 1.04
Steady-state kinetics of NADH:coenzyme Q oxidoreductase isolated from bovine heart mitochondria. J Bioenerg Biomembr (2002) 1.02
The Redox-Bohr group associated with iron-sulfur cluster N2 of complex I. J Biol Chem (2006) 0.99
Characteristics of the energy-transducing NADH-quinone oxidoreductase of Paracoccus denitrificans as revealed by biochemical, biophysical, and molecular biological approaches. J Bioenerg Biomembr (1993) 0.99
Steady-state kinetics of the reduction of coenzyme Q analogs by complex I (NADH:ubiquinone oxidoreductase) in bovine heart mitochondria and submitochondrial particles. Biochemistry (1996) 0.99
Kinetics, control, and mechanism of ubiquinone reduction by the mammalian respiratory chain-linked NADH-ubiquinone reductase. J Bioenerg Biomembr (1993) 0.95
Mitochondrial NADH-ubiquinone oxidoreductase (Complex I). Effect of substrates on the fragmentation of subunits by trypsin. J Biol Chem (1998) 0.94
Interaction of the membrane-bound succinate dehydrogenase with substrate and competitive inhibitors. Biochim Biophys Acta (1984) 0.93
The mitochondrial and prokaryotic proton-translocating NADH:ubiquinone oxidoreductases: similarities and dissimilarities of the quinone-junction sites. Biochim Biophys Acta (2003) 0.92
Structure-function studies of iron-sulfur clusters and semiquinones in the NADH-Q oxidoreductase segment of the respiratory chain. Biochim Biophys Acta (1998) 0.91
NADH-quinone oxidoreductase: PSST subunit couples electron transfer from iron-sulfur cluster N2 to quinone. Proc Natl Acad Sci U S A (1999) 0.91
Kinetics of the mitochondrial NADH-ubiquinone oxidoreductase interaction with hexammineruthenium(III). Biochim Biophys Acta (1993) 0.90
Reductive inactivation of the mitochondrial three subunit NADH dehydrogenase. Biochim Biophys Acta (1993) 0.89
The flavoprotein subcomplex of complex I (NADH:ubiquinone oxidoreductase) from bovine heart mitochondria: insights into the mechanisms of NADH oxidation and NAD+ reduction from protein film voltammetry. Biochemistry (2007) 0.89
A competitive inhibition of the mitochondrial NADH-ubiquinone oxidoreductase (complex I) by ADP-ribose. Biochim Biophys Acta (1997) 0.89
Interaction of the mitochondrial NADH-ubiquinone reductase with rotenone as related to the enzyme active/inactive transition. Biochim Biophys Acta (1997) 0.88
Respiratory complex I: structure, redox components, and possible mechanisms of energy transduction. Biochemistry (Mosc) (2001) 0.87
A novel strong competitive inhibitor of complex I. FEBS Lett (2005) 0.87
Steady-state kinetics of low molecular weight (type-II) NADH dehydrogenase. Biochim Biophys Acta (1976) 0.86
Kinetics of the mitochondrial three-subunit NADH dehydrogenase interaction with hexammineruthenium(III). Biochim Biophys Acta (1995) 0.85
The pathway of electron transfer in NADH:Q oxidoreductase. Biochim Biophys Acta (1989) 0.82
The effect of delta mu H+ on the interaction of rotenone with complex I of submitochondrial particles. Biochim Biophys Acta (1992) 0.79
New evidence for the dimeric nature of NADH:Q oxidoreductase in bovine-heart submitochondrial particles. Biochim Biophys Acta (1990) 0.78
ATR-FTIR redox difference spectroscopy of Yarrowia lipolytica and bovine complex I. Biochemistry (2006) 0.78
Architecture of succinate dehydrogenase and reactive oxygen species generation. Science (2003) 4.40
Second hand smoke stimulates tumor angiogenesis and growth. Cancer Cell (2003) 2.17
Doxorubicin cardiomyopathy. Cardiology (2009) 1.99
A sphingosine kinase 1 mutation sensitizes the myocardium to ischemia/reperfusion injury. Cardiovasc Res (2007) 1.91
Generation of superoxide by the mitochondrial Complex I. Biochim Biophys Acta (2006) 1.67
Cardiac matrix metalloproteinase-2 expression independently induces marked ventricular remodeling and systolic dysfunction. Am J Physiol Heart Circ Physiol (2006) 1.63
CD133 is a marker for long-term repopulating murine epidermal stem cells. J Invest Dermatol (2012) 1.58
In situ assay of the intramitochondrial enzymes: use of alamethicin for permeabilization of mitochondria. Anal Biochem (2003) 1.54
Signals from type 1 sphingosine 1-phosphate receptors enhance adult mouse cardiac myocyte survival during hypoxia. Am J Physiol Heart Circ Physiol (2007) 1.50
Cardioprotection mediated by sphingosine-1-phosphate and ganglioside GM-1 in wild-type and PKC epsilon knockout mouse hearts. Am J Physiol Heart Circ Physiol (2002) 1.45
Sphingosine kinase activation mediates ischemic preconditioning in murine heart. Circulation (2004) 1.44
Structural and computational analysis of the quinone-binding site of complex II (succinate-ubiquinone oxidoreductase): a mechanism of electron transfer and proton conduction during ubiquinone reduction. J Biol Chem (2005) 1.38
Cardiac transgenic matrix metalloproteinase-2 expression directly induces impaired contractility. Cardiovasc Res (2005) 1.30
A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimers. Biochem J (2003) 1.29
Transgenic MMP-2 expression induces latent cardiac mitochondrial dysfunction. Biochem Biophys Res Commun (2007) 1.23
Differences among cell types in NAD(+) compartmentalization: a comparison of neurons, astrocytes, and cardiac myocytes. J Neurosci Res (2007) 1.22
Crystallographic studies of the Escherichia coli quinol-fumarate reductase with inhibitors bound to the quinol-binding site. J Biol Chem (2002) 1.22
Dimethylsphingosine and FTY720 inhibit the SK1 form but activate the SK2 form of sphingosine kinase from rat heart. J Biochem Mol Toxicol (2007) 1.21
EPR characterization of ubisemiquinones and iron-sulfur cluster N2, central components of the energy coupling in the NADH-ubiquinone oxidoreductase (complex I) in situ. J Bioenerg Biomembr (2002) 1.17
Sphingosine 1-phosphate is an important endogenous cardioprotectant released by ischemic pre- and postconditioning. Am J Physiol Heart Circ Physiol (2009) 1.16
Moderate alcohol consumption induces sustained cardiac protection by activating PKC-epsilon and Akt. Am J Physiol Heart Circ Physiol (2002) 1.16
A structural model for binding of the serine-rich repeat adhesin GspB to host carbohydrate receptors. PLoS Pathog (2011) 1.15
Deletion of the sphingosine kinase-1 gene influences cell fate during hypoxia and glucose deprivation in adult mouse cardiomyocytes. Cardiovasc Res (2007) 1.13
Cardiac ischemia-reperfusion injury induces matrix metalloproteinase-2 expression through the AP-1 components FosB and JunB. Am J Physiol Heart Circ Physiol (2006) 1.12
Role of sphingosine kinase activity in protection of heart against ischemia reperfusion injury. Med Sci Monit (2006) 1.11
Poly(ADP-ribose) polymerase-1 hyperactivation and impairment of mitochondrial respiratory chain complex I function in reperfused mouse hearts. Am J Physiol Heart Circ Physiol (2006) 1.10
Ischaemic postconditioning protects isolated mouse hearts against ischaemia/reperfusion injury via sphingosine kinase isoform-1 activation. Cardiovasc Res (2008) 1.07
Combined sphingosine, S1P and ischemic postconditioning rescue the heart after protracted ischemia. Biochem Biophys Res Commun (2008) 1.07
Sphingosine can pre- and post-condition heart and utilizes a different mechanism from sphingosine 1-phosphate. J Biochem Mol Toxicol (2008) 1.07
High-density lipoprotein determines adult mouse cardiomyocyte fate after hypoxia-reoxygenation through lipoprotein-associated sphingosine 1-phosphate. Am J Physiol Heart Circ Physiol (2010) 1.07
Effect of anoxia/reperfusion on the reversible active/de-active transition of NADH-ubiquinone oxidoreductase (complex I) in rat heart. Biochim Biophys Acta (2002) 1.07
Molecular determinants of responses to myocardial ischemia/reperfusion injury: focus on hypoxia-inducible and heat shock factors. Cardiovasc Res (2004) 1.06
The quinone binding site in Escherichia coli succinate dehydrogenase is required for electron transfer to the heme b. J Biol Chem (2006) 1.04
A rapid radioassay for sphingosine kinase. Anal Biochem (2005) 1.02
S1P lyase: a novel therapeutic target for ischemia-reperfusion injury of the heart. Am J Physiol Heart Circ Physiol (2011) 1.02
What are the sources of hydrogen peroxide production by heart mitochondria? Biochim Biophys Acta (2010) 1.02
Pyrroloquinoline quinone preserves mitochondrial function and prevents oxidative injury in adult rat cardiac myocytes. Biochem Biophys Res Commun (2007) 0.99
Polarizability of G4-DNA observed by electrostatic force microscopy measurements. Nano Lett (2007) 0.99
High-resolution STM imaging of novel poly(G)-poly(C) DNA molecules. J Phys Chem B (2006) 0.98
Structure of Escherichia coli succinate:quinone oxidoreductase with an occupied and empty quinone-binding site. J Biol Chem (2009) 0.97
Differences in protonation of ubiquinone and menaquinone in fumarate reductase from Escherichia coli. J Biol Chem (2006) 0.97
Escherichia coli succinate dehydrogenase variant lacking the heme b. Proc Natl Acad Sci U S A (2007) 0.97
Active/de-active transition of respiratory complex I in bacteria, fungi, and animals. Biochim Biophys Acta (2003) 0.97
The bacterial flagellar switch complex is getting more complex. EMBO J (2008) 0.96
Comparison of pyrroloquinoline quinone and/or metoprolol on myocardial infarct size and mitochondrial damage in a rat model of ischemia/reperfusion injury. J Cardiovasc Pharmacol Ther (2006) 0.96
MnSOD in mouse heart: acute responses to ischemic preconditioning and ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol (2005) 0.95
Protein kinase C epsilon dependence of the recovery from down-regulation of S1P1 G protein-coupled receptors of T lymphocytes. J Biol Chem (2003) 0.95
N-terminal truncated intracellular matrix metalloproteinase-2 induces cardiomyocyte hypertrophy, inflammation and systolic heart failure. PLoS One (2013) 0.94
Chirality of silver nanoparticles synthesized on DNA. J Am Chem Soc (2006) 0.94
A threonine on the active site loop controls transition state formation in Escherichia coli respiratory complex II. J Biol Chem (2008) 0.94
Energy-dependent transformation of F0.F1-ATPase in Paracoccus denitrificans plasma membranes. J Biol Chem (2004) 0.94
Inhibitory effect of palmitate on the mitochondrial NADH:ubiquinone oxidoreductase (complex I) as related to the active-de-active enzyme transition. Biochem J (2005) 0.94
Acute vincristine pretreatment protects adult mouse cardiac myocytes from oxidative stress. J Mol Cell Cardiol (2007) 0.94
Electron transfer and catalytic control by the iron-sulfur clusters in a respiratory enzyme, E. coli fumarate reductase. J Am Chem Soc (2005) 0.94
Cardiomyocyte S1P1 receptor-mediated extracellular signal-related kinase signaling and desensitization. J Cardiovasc Pharmacol (2009) 0.93
Mitochondrial hydrogen peroxide production as determined by the pyridine nucleotide pool and its redox state. Biochim Biophys Acta (2012) 0.93
Sphingolipid signaling and treatment during remodeling of the uninfarcted ventricular wall after myocardial infarction. Am J Physiol Heart Circ Physiol (2009) 0.93
Vincristine attenuates doxorubicin cardiotoxicity. Biochem Biophys Res Commun (2008) 0.93
The mitochondrial and prokaryotic proton-translocating NADH:ubiquinone oxidoreductases: similarities and dissimilarities of the quinone-junction sites. Biochim Biophys Acta (2003) 0.92
Defining the Q-site of Escherichia coli fumarate reductase by site-directed mutagenesis, fluorescence quench titrations and EPR spectroscopy. FEBS J (2005) 0.92
Cardiac transgenic matrix metalloproteinase-2 expression induces myxomatous valve degeneration: a potential model of mitral valve prolapse disease. Cardiovasc Pathol (2008) 0.92
Partitioning of superoxide and hydrogen peroxide production by mitochondrial respiratory complex I. Biochim Biophys Acta (2013) 0.92
A novel intracellular isoform of matrix metalloproteinase-2 induced by oxidative stress activates innate immunity. PLoS One (2012) 0.92
Low dose N, N-dimethylsphingosine is cardioprotective and activates cytosolic sphingosine kinase by a PKCepsilon dependent mechanism. Cardiovasc Res (2006) 0.91
Fumarate reductase and succinate oxidase activity of Escherichia coli complex II homologs are perturbed differently by mutation of the flavin binding domain. J Biol Chem (2006) 0.91
Formation and characterization of stable human serum albumin-tris-malonic acid [C60]fullerene complex. Bioconjug Chem (2005) 0.91
A sphingosine kinase form 2 knockout sensitizes mouse myocardium to ischemia/reoxygenation injury and diminishes responsiveness to ischemic preconditioning. Oxid Med Cell Longev (2011) 0.90
Effect of oxygen on activation state of complex I and lack of oxaloacetate inhibition of complex II in Langendorff perfused rat heart. FEBS Lett (2004) 0.90
Epinephrine is required for normal cardiovascular responses to stress in the phenylethanolamine N-methyltransferase knockout mouse. Circulation (2007) 0.89
Electron-transfer mechanisms through biological redox chains in multicenter enzymes. J Am Chem Soc (2002) 0.89
Molecular identification of the enzyme responsible for the mitochondrial NADH-supported ammonium-dependent hydrogen peroxide production. FEBS Lett (2010) 0.89
Pyrroloquinoline quinone (PQQ) decreases myocardial infarct size and improves cardiac function in rat models of ischemia and ischemia/reperfusion. Cardiovasc Drugs Ther (2004) 0.88
Adult cardiac fibroblasts null for sphingosine kinase-1 exhibit growth dysregulation and an enhanced proinflammatory response. J Mol Cell Cardiol (2007) 0.88
Absence of NADH channeling in coupled reaction of mitochondrial malate dehydrogenase and complex I in alamethicin-permeabilized rat liver mitochondria. Biochem Biophys Res Commun (2004) 0.88
Minocycline protects cardiac myocytes against simulated ischemia–reperfusion injury by inhibiting poly(ADP-ribose) polymerase-1. J Cardiovasc Pharmacol (2010) 0.87
A novel strong competitive inhibitor of complex I. FEBS Lett (2005) 0.87
The quinone-binding and catalytic site of complex II. Biochim Biophys Acta (2010) 0.87
Altering pyrroloquinoline quinone nutritional status modulates mitochondrial, lipid, and energy metabolism in rats. PLoS One (2011) 0.87
Assembling of G-strands into novel tetra-molecular parallel G4-DNA nanostructures using avidin-biotin recognition. Nucleic Acids Res (2008) 0.86
Topography and chemical reactivity of the active-inactive transition-sensitive SH-group in the mitochondrial NADH:ubiquinone oxidoreductase (Complex I). Biochim Biophys Acta (2006) 0.86
The transition between active and de-activated forms of NADH:ubiquinone oxidoreductase (Complex I) in the mitochondrial membrane of Neurospora crassa. Biochem J (2003) 0.86
Energy-linked binding of Pi is required for continuous steady-state proton-translocating ATP hydrolysis catalyzed by F0.F1 ATP synthase. Biochemistry (2006) 0.85
Transgenic expression of matrix metalloproteinase-2 induces coronary artery ectasia. Int J Exp Pathol (2010) 0.84
Expression of a Gi-coupled receptor in the heart causes impaired Ca2+ handling, myofilament injury, and dilated cardiomyopathy. Am J Physiol Heart Circ Physiol (2007) 0.84
Perturbation of the quinone-binding site of complex II alters the electronic properties of the proximal [3Fe-4S] iron-sulfur cluster. J Biol Chem (2011) 0.83
Mutation of the heme axial ligand of Escherichia coli succinate-quinone reductase: implications for heme ligation in mitochondrial complex II from yeast. Biochim Biophys Acta (2010) 0.83
Using rational screening and electron microscopy to optimize the crystallization of succinate:ubiquinone oxidoreductase from Escherichia coli. Acta Crystallogr D Biol Crystallogr (2003) 0.82